Cancer-treatment devices maker Elekta’s $25 million Chinese order is its largest to date.

Stockholm-based medical device company Elekta (STO:EKTA B) landed a $25 million contract to provide its Leksell Gamma Knife Perfexion systems to the People’s Republic of China, marking the largest order to date for the Leksell system.

The new contract even further cements the Chinese market as the 2nd largest for Elekta, which has a corner on about 48% of the radiation therapy market there.